5079 related articles for article (PubMed ID: 6095550)
21. Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas.
Hegazy MA; Kotb SZ; Sakr H; El Dosoky E; Amer T; Hegazi RA; Farouk O
Ann Surg Oncol; 2007 Feb; 14(2):568-76. PubMed ID: 17094027
[TBL] [Abstract][Full Text] [Related]
22. [Regional perfusion of the extremity - experience in 81 patients with malignant melanomas (author's transl)].
Ghussen F; Groth W; Nagel K
Z Hautkr; 1981 Jul; 56(14):911-20. PubMed ID: 7269716
[TBL] [Abstract][Full Text] [Related]
23. Isolated limb perfusion for melanoma.
Kroon BB; Noorda EM; Vrouenraets BC; van Slooten GW; Nieweg OE
Surg Oncol Clin N Am; 2008 Oct; 17(4):785-94, viii-ix. PubMed ID: 18722918
[TBL] [Abstract][Full Text] [Related]
24. Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities.
Papa MZ; Klein E; Karni T; Koller M; Davidson B; Azizi E; Ben-Ari G
Am J Surg; 1996 Apr; 171(4):416-20. PubMed ID: 8604833
[TBL] [Abstract][Full Text] [Related]
25. [On the method of hyperthermic chemotherapy by regional isolated perfusion for tumors of lower extremities].
Xu SW; Chen F; Chao YH
Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):310-3. PubMed ID: 7805565
[TBL] [Abstract][Full Text] [Related]
26. Blood leakage and melphalan leakage from the perfusion circuit during regional hyperthermic perfusion for malignant melanoma.
Hafström L; Hugander A; Jönsson PE; Westling H; Ehrsson H
Cancer Treat Rep; 1984 Jun; 68(6):867-72. PubMed ID: 6733699
[TBL] [Abstract][Full Text] [Related]
27. Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.
Lejeune F; Liénard D; Eggermont A; Schraffordt Koops H; Rosenkaimer F; Gérain J; Klaase J; Kroon B; Vanderveken J; Schmitz P
J Infus Chemother; 1995; 5(2):73-81. PubMed ID: 8521239
[TBL] [Abstract][Full Text] [Related]
28. Isolated limb perfusion: the European experience.
Lejeune FJ; Kroon BB; Di Filippo F; Hoekstra HJ; Santinami M; Liénard D; Eggermont AM
Surg Oncol Clin N Am; 2001 Oct; 10(4):821-32, ix. PubMed ID: 11641093
[TBL] [Abstract][Full Text] [Related]
29. TNF alpha in isolated perfusion systems: success in the limb, developments for the liver credits, debits and future perspectives.
Eggermont AM
Anticancer Res; 1998; 18(5D):3899-905. PubMed ID: 9854502
[TBL] [Abstract][Full Text] [Related]
30. [Regional perfusion therapy of malignant tumors of the extremities].
Boeckl O; Hell E; Zimmermann G
Dtsch Med Wochenschr; 1970 Mar; 95(13):707-10. PubMed ID: 4985407
[No Abstract] [Full Text] [Related]
31. Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities.
Hoekstra HJ; Schraffordt Koops H; Molenaar WM; Oldhoff J
Cancer; 1987 Oct; 60(8):1703-7. PubMed ID: 2820562
[TBL] [Abstract][Full Text] [Related]
32. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
Di Filippo F; Giacomini P; Rossi CR; Santinami M; Garinei R; Anzà M; Deraco M; Botti C; Perri P; Cavaliere F; Di Angelo P; Sofra C; Sperduti I; Pasqualoni R; Di Filippo S; Corrias F; Armenti A; Ferraresi V
In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
[TBL] [Abstract][Full Text] [Related]
33. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
Lejeune FJ; Pujol N; Liénard D; Mosimann F; Raffoul W; Genton A; Guillou L; Landry M; Chassot PG; Chiolero R; Bischof-Delaloye A; Leyvraz S; Mirimanoff RO; Bejkos D; Leyvraz PF
Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
[TBL] [Abstract][Full Text] [Related]
34. [O2 utilization during hyperthermic extremity perfusion with rhTNF alpha and melphalan].
Haier J; Hohenberger P; Beck K; Schlag PM
Langenbecks Arch Chir; 1997; 382(3):128-33. PubMed ID: 9324610
[TBL] [Abstract][Full Text] [Related]
35. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
[TBL] [Abstract][Full Text] [Related]
36. Palliation of regional symptoms of advanced extremity melanoma by isolated limb perfusion with melphalan and high-dose tumor necrosis factor.
Fraker DL; Alexander HR; Andrich M; Rosenberg SA
Cancer J Sci Am; 1995; 1(2):122-30. PubMed ID: 9166465
[TBL] [Abstract][Full Text] [Related]
37. Surgical chemotherapy in the management of melanoblastoma of the lower extremities.
Rahóty P; Besznyák I; Erdélyi-Tóth V; Sulvok Z; Péley G
Acta Chir Hung; 1997; 36(1-4):282-3. PubMed ID: 9408375
[TBL] [Abstract][Full Text] [Related]
38. Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma.
Hayes AJ; Neuhaus SJ; Clark MA; Thomas JM
Ann Surg Oncol; 2007 Jan; 14(1):230-8. PubMed ID: 17066234
[TBL] [Abstract][Full Text] [Related]
39. [Isolated infusion effective in melanoma and sarcoma. Good alternative for regional isolated cytostatic perfusion].
Kroon HM; Thompson JF; Hoekstra HJ
Ned Tijdschr Geneeskd; 2009 Mar; 153(11):508-14. PubMed ID: 19402327
[No Abstract] [Full Text] [Related]
40. Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
Brady MS; Brown K; Patel A; Fisher C; Marx W
Melanoma Res; 2009 Apr; 19(2):106-11. PubMed ID: 19282789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
